HOME >> MEDICINE >> NEWS
Researchers discover new way to stimulate brain to release antioxidants

A joint research effort between researchers at the Burnham Institute for Medical Research in La Jolla, CA, and a team from Japan (Iwate University, Osaka City University, Gifu University, Iwate Medical University) has discovered a novel way to treat stroke and neurodegenerative disorders. This approach works by inducing nerve cells in the brain and the spine to release natural antioxidants that protect nerve cells from stress and free radicals that lead to neurodegenerative diseases. Until this discovery, researchers were unable to induce release of these specific antioxidants directly in nerve cells, at the site where damage and degeneration occurs.

In stroke and various neurodegenerative disorders, such as Alzheimer's disease and Lou Gehrig's disease, glutamate, an amino acid found in high quantities in the brain, is thought to accumulate. At normal concentrations, glutamate acts as a neurotransmitter that nerves use to communicate. However, at excessive levels glutamate is toxic, resulting in over stimulation of nerve cells, known as excitotoxicity, and causing excessive stress on the nerve cells eventually ending in cell death. Studies described in this report suggest that NEPPs (short for NEurite outgrowth-Promoting Prostaglandins), compounds that accumulate in nerve cells, prevent nerve damage by activating the Keap1/Nrf2 pathway that regulates the production of antioxidants which relieve cells of damaging free radicals that result from excitotoxicity.

"This is the first reported evidence that this protective response can be activated directly in nerve cells to release antioxidants and counter oxidative stress," said Stuart Lipton, M.D., Ph.D., Director of the Del E. Webb Center for Neurosciences and Aging at the Burnham Institute and senior author of the study. "These findings provide support for further investigation of NEPP drugs to potentially treat ischemic stroke, multiple sclerosis, Alzheimer's disease, Lou Gehrig's disease and other
'"/>

Contact: Nancy Beddingfield
nbeddingfield@burnham.org
858-646-3146
Burnham Institute
9-Jan-2006


Page: 1 2

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
3. Researchers link metal ions to neurodegenerative disease
4. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
5. Researchers call for investigation into links between khat use and psychiatric disorders
6. Researchers use MRI to predict recovery after spinal cord injury
7. Researchers find deadly prescription drug effects 6 years before FDA
8. Researchers investigate impact of lifestyle on GI health
9. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
10. Researchers discover how antibiotic inhibits bacterial growth
11. Researchers urge caution in using ESAs for cancer-related anemia

Post Your Comments:
(Date:4/21/2015)... 2015 Invictus Medical has secured ... university for a second innovative technology aimed at ... to newborn infants’ cognitive development. , “This technology ... we have identified through extensive interviews and input ... Hutchinson, Invictus Medical’s Chief Technology Officer. “We believe ...
(Date:4/20/2015)... Heritage Woods of Centralia, a Gardant affordable assisted ... Spaghetti Dinner from 4 p.m. to 6 p.m. on ... Centralia, Illinois, houses senior living apartments, affordable assisted living ... older. , Guests are invited to tour the community ... seniors. After the tours, they can take home spaghetti ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 Reality show ... and girlfriends at the twentieth annual Michigan International Women’s ... in Novi. , “There is lots to see and ... to shopping for fashion and gifts,” said Beth Anderson, ... are entertaining and encouraging with appearances from Randy Fenoli ...
(Date:4/20/2015)... The partners of Urgent Care of Westchester and Riverdale ... Med Spa with a special event. Residents of Westchester County ... p.m. on April 24 on 909 Midland Ave. in Yonkers, ... will also get the chance to win free services from ... purchase, as well as up to 40 percent discounts on ...
(Date:4/20/2015)... The American Association for Physician Leadership® ... Improvement as the 2015 winner of the Leape Ahead ... Meeting, April 18, in Las Vegas, Nevada. , ... safety can be dramatically improved,” said Peter Angood, MD, ... Medicine and its Academy for Quality and Safety should ...
Breaking Medicine News(10 mins):Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 3Health News:Bella Diosa Says Hello to Yonkers Community with Spa Party 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 3
(Date:4/20/2015)... Calif. , April 20, 2015  Published ... positive trends in the ability of Neuraltus ... progression of amyotrophic lateral sclerosis (ALS, also known ... 6-month treatment period. While NP001,s slowing of decline ... study was not statistically significant, clinically meaningful slowing ...
(Date:4/20/2015)... April 20, 2015  OpGen, Inc., a molecular ... of its executive management team with the appointments ... executive Kevin Krenitsky , M.D. as president, ... chief financial officer. With more ... global diagnostic and biotechnology operations, including senior commercial ...
(Date:4/20/2015)... , April 20, 2015 ... disease and specifically autism drug candidates, a few viable ... such as fragile X syndrome.   Biotech Companies in ... (NASDAQ: CYTR ), Trovagene, Inc., (NASDAQ: TROV ... Laboratories (NYSE: ABT ) & Lexicon Pharmaceuticals, Inc. ...
Breaking Medicine Technology:Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 2OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 3OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 4Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 2Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 3Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 4Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 5Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 6
Cached News: